Castle Biosciences CSTL Q2 2025 earnings
Reported August 4, 2025 · After market close
Revenue$86.2MBeat by $18.2M
EPS$0.15Beat by $0.66
Revenue estimate$68.0M
EPS estimate-$0.51
Next report
Date not yet announcedFinancials
Q2 2025Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
Ask the moment Castle Biosciences reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Castle Biosciences report Q2 2025 earnings?
- Castle Biosciences (CSTL) reported Q2 2025 earnings on August 4, 2025 after market close.
- What were Castle Biosciences's Q2 2025 revenue and EPS?
- Castle Biosciences reported revenue of $86.2M and eps of $0.15 for Q2 2025.
- Did Castle Biosciences beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $68.0M by $18.2M. EPS beat the consensus estimate of $-0.51 by $0.66.
- How did Castle Biosciences's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 0.9% from $87.0M a year earlier and eps declined 51.6% from $0.31.
- Where can I find Castle Biosciences's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001447362-25-000097) directly on SEC EDGAR. The filing index links above go to sec.gov.